The Testosterone Optimization Boom: FDA Shifts in 2026

Key Takeaways

• Testosterone prescriptions surged from 7.3 million in 2019 to over 11 million by 2024, with nearly 14% of men under 40 currently using or having used testosterone replacement therapy (TRT), making 2026 a watershed year as FDA restrictions ease and new oral options expand access.
• FDA removed age-related safety warnings for TRT in 2026 following the TRAVERSE trial of over 5,200 men, which found no meaningful increase in major cardiovascular events, though higher rates of atrial fibrillation and pulmonary embolism were observed.
• KYZATREX, a new FDA-approved oral testosterone, restores levels in up to 96% of men without the liver concerns of older oral forms or the hassle of injections and gels, while telehealth platforms now offer personalized therapy starting at $99 to $300 monthly.
• Diagnostic and prescribing gaps remain widespread, with only a small number of men receiving guideline-concordant testing before starting TRT, which causes infertility within months and requires lifelong commitment as natural production shuts down.
• Strength training, recovery science, and wearable-driven biofeedback form the foundation of evidence-based male fitness in 2026, with functional training dominant and over 70% of wearable users now using data to guide exercise and recovery strategies.
• The U.S. Men's Health Supplements Market reached $9.8 billion in 2025 and is projected to hit $23.15 billion by 2035, reflecting growing interest in testosterone optimization alongside cardiovascular health concerns as heart disease remains the leading cause of death.

Why Testosterone Therapy Is Having a Mainstream Moment in 2026

Testosterone replacement therapy has moved from clinical treatment to cultural conversation. Testosterone prescriptions climbed from approximately 7.3 million in 2019 to over 11 million by 2024, driven by telehealth access, social media visibility, and growing interest among younger men. Nearly 14% of men under 40 are currently using or have used TRT, and about 40% of men under 40 have expressed interest in testosterone optimization, according to Harvard Health reporting.

The business case is clear. The U.S. Men's Health Supplements Market was valued at approximately $9.797 billion in 2025 and is projected to reach around $23.15 billion by 2035, reflecting broader wellness trends around male vitality, muscle mass, energy, and sexual health. Testosterone plays a vital role in all these areas, and when levels decline, it can affect nearly every dimension of daily life.

The FDA Removed Key Age-Related Restrictions This Year

In a significant regulatory shift, the FDA removed the limitation of use stating that the safety and effectiveness of testosterone replacement therapy in men with age-related hypogonadism have not been established. This change followed the TRAVERSE trial, involving more than 5,200 men, which found no meaningful increase in the risk of major adverse cardiovascular events, including heart attack and stroke, among men receiving testosterone replacement therapy.

An FDA expert panel conclusion in December 2025 stated that TRT does not increase cardiovascular or prostate cancer risk. Under requested revisions, testosterone replacement therapy would be contraindicated only in men with metastatic prostate cancer. These changes represent a major policy evolution and have fueled expanded prescribing and patient demand heading into 2026.

New Oral Testosterone Options Are Changing Access and Convenience

KYZATREX, a new FDA-approved oral testosterone, has been shown to restore testosterone levels in up to 96% of men, and unlike older oral forms that had liver concerns, this new option doubles free testosterone on average without the hassle of injections or gels, per Harvard Health reporting. For men who found injections inconvenient or were concerned about topical transfer to partners or children, oral testosterone represents a practical breakthrough.

Telehealth has also expanded treatment options. Personalized enclomiphene therapy is now available through online platforms, a treatment that restores the body's natural testosterone production without compromising fertility, making it appealing for younger men or those planning families. In 2026, the monthly cost for TRT generally ranges from $99 to over $500 depending on the chosen delivery model, with telehealth clinics offering all-inclusive monthly fees often falling between $99 and $300, according to community discussions.

The Diagnostic and Safety Gaps That Should Concern Everyday Men

Despite expanded access, prescribing practices remain inconsistent. Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic testing, Harvard Health reported. This includes confirming low testosterone through multiple early-morning blood tests and ruling out underlying causes such as sleep apnea, obesity, or medication side effects.

TRT is not a casual intervention. TRT causes infertility within months and shuts down the body's natural testosterone production, making it a lifelong commitment since recovery can take months to years after stopping, especially for older men who've used it longer. The TRAVERSE study found higher rates of atrial fibrillation and pulmonary embolism, and the FDA recently mandated labeling changes noting potential blood pressure increases.

Men with Type 2 diabetes face additional considerations. Up to 40% of men with Type 2 diabetes have testosterone deficiency, but the interplay between metabolic health, weight, and hormone levels requires careful medical management, not just a prescription.

Strength Training, Recovery, and Cardiovascular Health Remain the Foundation

While testosterone conversations dominate wellness discourse in 2026, the fundamentals have not changed. Strength training builds muscle, strengthens bones, supports weight management, boosts cardiovascular health, and delivers benefits that go far beyond the mirror, according to Harvard Health. Functional training has firmly established itself as the dominant training philosophy this year, focusing on exercises that mimic real-world movement patterns and building strength, coordination, and mobility simultaneously.

Recovery science has moved from elite athletes into mainstream fitness culture. Sleep is the most science-backed recovery method, with high-quality, consistent sleep consistently outperforming even the priciest gadgets. Sleep extension and maintaining a consistent sleep schedule are proven to maximize recovery better than cold plunges or compression boots. Over 70% of wearable users report using their data to guide exercise and recovery strategies, while fitness professionals are leveraging biofeedback to fine-tune workout intensity, gauge readiness, and help prevent overtraining.

Cardiovascular disease is the leading cause of death in the United States, and exercise training has been shown to reduce cardiovascular mortality by approximately 20% to 30% in secondary prevention populations and to decrease the incidence of major adverse cardiovascular events by around 25% compared to standard medical care alone, per American Heart Association guidance. Heart health does not develop overnight, and prevention remains more effective than intervention.

What This Means for Readers

Editorial analysis — not reported fact:

The testosterone optimization boom reflects real hormonal concerns for some men, but it also reflects aggressive marketing, social media amplification, and a healthcare system that sometimes prioritizes convenience over thoroughness. If you are experiencing fatigue, low libido, difficulty building muscle, or mood changes, a comprehensive diagnostic workup is the responsible first step, not a telehealth prescription after a single questionnaire.

For men under 40 considering TRT, the fertility and natural production shutdown issues are not minor. Enclomiphene and lifestyle interventions such as strength training, sleep optimization, weight management, and stress reduction can meaningfully raise testosterone levels without lifelong pharmaceutical dependency. Most men notice improvements in energy and mood within two to four weeks of TRT, while muscle mass and strength improvements typically take three to six months, but these same timelines apply to consistent training and recovery habits without hormones.

The new oral options and FDA regulatory changes expand legitimate access for men with clinically diagnosed hypogonadism, which is a positive development. But the blurring line between treatment and enhancement, combined with inconsistent diagnostic standards, means everyday consumers need to approach this trend with informed skepticism and a clear-eyed conversation with a qualified healthcare provider who orders the right tests, considers root causes, and discusses both risks and alternatives.

Strength training, cardiovascular exercise, seven to nine hours of quality sleep, stress management, and attention to nutrition remain the most evidence-based, side-effect-free interventions for energy, muscle mass, mood, and longevity. Wearables such as WHOOP and Garmin are empowering men to train smarter, not just harder, by using heart rate zone data and recovery metrics to avoid overtraining and maximize adaptation. These tools cost far less than TRT, carry no medical risk, and build sustainable habits that compound over decades.

Men considering testosterone therapy should consult an endocrinologist or urologist with expertise in male hormonal health, not just a primary care provider or telehealth platform. Appropriate testing includes multiple early-morning total and free testosterone measurements, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and evaluation for secondary causes such as sleep disorders, thyroid dysfunction, or medication effects. If you start TRT, ongoing monitoring for cardiovascular markers, hematocrit, prostate health, and fertility is essential.

Sources & Further Reading

• National Center for Biotechnology Information: Testosterone prescription trends from 2019 to 2024 — peer-reviewed data on the prescription surge and demographic patterns
• Endocrine Society: FDA removes limitation of use for testosterone replacement therapy — official announcement of the regulatory change and TRAVERSE trial findings
• Harvard Health Publishing: Is testosterone therapy safe? Take a breath before you take the plunge — comprehensive overview of KYZATREX, diagnostic gaps, fertility concerns, and prescribing trends
• U.S. Men's Health Supplements Market analysis — market valuation and growth projections through 2035
• Reddit testosterone community: TRT cost breakdown, 2026 edition — consumer perspectives on pricing and telehealth access
• Harvard Health Publishing: Strength training builds more than muscles — evidence-based overview of resistance training benefits
• American Heart Association: Exercise training and cardiovascular disease prevention — peer-reviewed guidance on exercise's role in reducing cardiovascular mortality

Editorial coverage of publicly reported health, fitness, wellness, nutrition, and active living developments. Move Weekly has no commercial relationship with any companies, gyms, studios, brands, events, experts, products, or organizations named.